Health Care • Industrial Specialties
$6.64 ▲ +0.24
(+3.75%)
MKT CAP: $80.7M • VOL: 12.6K
52W L $3 52W H $9
ROARABLE / RQD
D- • 40/100
PIOTROSKI
4 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$6
MEDIAN
$7
MEAN
$8
HIGH
$9
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE NTRB TAPE
NTRB // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $8.03 | $7.64 | 2025-02-14 | $6.04 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $8.37 | $7.84 | 2025-02-06 | $6.24 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $7.57 | $7.30 | 2025-01-29 | $6.37 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $6.77 | — | 2025-01-17 | $6.51 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $5.84 | $6.31 | 2025-01-09 | $5.91 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $7.90 | $6.91 | 2024-12-18 | $5.78 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $6.44 | $6.71 | 2024-12-04 | $6.18 | -4.3% | 48% | C |